This month, AMA Journal of Ethics' theme editor, Gaurav Jay Dhiman, a third-year medical student at the University of Miami Leonard M. Miller School of Medicine, interviewed Jonathan D. Moreno, PhD, on the role of bioethicists in military research and ethical issues in research on people with disabilities.

Elderly persons should not be excluded from participation in clinical trials for cardiovascular drugs since that population comprises the largest number of patients with cardiovascular disease.

Undue influence, which occurs when prospective research participants who otherwise would not enroll are induced to enter studies that might pose significant risks, may also involve social injustices such as unequal payment and participant selection methods that unequally distribute the potential harms and benefits of research.

The continuance of public and institutional support for medical research after the publicized deaths of human research participants in the 1950s contrasts sharply with the disciplining of institutions responsible for two such deaths in recent decades, which suggests that medical research participants are no longer receiving public recognition for their contributions to science.

High-performing doctors willing to work to alleviate the shortage of medical care in the United States should be encouraged to do so, not prevented because of their countries of origin.

Because the number of patients undergoing genetic testing is increasing, medical staff should be conscientious about their patients' potential needs for genetic counseling and be ready to advise patients on communicating their diagnoses to at-risk family members or refer them to genetic counselors.

The AMA Code of Medical Ethics’ opinion on disclosure of patients’ genetic test results.

The Wisconsin Academy for Rural Medicine seeks candidates with an increased probability of practicing in rural Wisconsin, delivers the curriculum in collaboration with rural partners, and encourages students' interest in rural practice and living.

A discussion of ethics concerns in psychiatric genetics focusing on predictive genetic testing, psychosocial consequences for patients, effects on family and communities, and the ethics of some emerging technologies.

The FDA's decision to put a black-box warning on antidepressant labels may be misleading because it implies that antidepressants have definitely been found to increase suicidality in adolescents, when in fact there is merely a lack of clear evidence about their safety.